Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 26, 2021; 9(21): 6091-6101
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.6091
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.6091
Figure 1 Fluctuation of factor VII activity and corresponding prothrombin time value in the pregnant woman.
Medication: Intravenous injection of recombinant factor VIIa (NovoSeven®, Novo Nordisk A/S, Bagsvaerd, Denmark) 5 mg, (90 μg/kg). PT: Prothrombin time.
- Citation: Yang Y, Zeng YC, Rumende P, Wang CG, Chen Y. Diagnosis and treatment discussion of congenital factor VII deficiency in pregnancy: A case report. World J Clin Cases 2021; 9(21): 6091-6101
- URL: https://www.wjgnet.com/2307-8960/full/v9/i21/6091.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i21.6091